Hope B T, Crombag H S, Jedynak J P, Wise R A
National Institute on Drug Abuse, National Institutes of Health/DHHS, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA.
J Neurochem. 2005 Feb;92(3):536-45. doi: 10.1111/j.1471-4159.2004.02891.x.
Neuroadaptations induced by high-dose cocaine treatment have been hypothesized to persist after the cessation of drug treatment and mediate the expression of sensitization and tolerance to cocaine. We looked for evidence of these neuroadaptations in rats receiving more modest behaviorally effective cocaine treatments. Rats were exposed to either a sensitizing regimen of seven once-daily injections of 15 mg/kg cocaine or a tolerance-producing regimen involving a continuous infusion of the same daily dose. We assessed enzyme activity levels of protein kinase A and adenylate cyclase, and protein levels of tyrosine hydroxylase, cdk5 and neurofilaments in the nucleus accumbens and ventral tegmental area. Only protein kinase A activity levels were altered by cocaine treatment, but this alteration persisted for only 7 days, whereas a sensitized locomotor response was still evident at 21 days. Although behavioral tolerance to cocaine was seen the day after the termination of treatment, none of the molecular measures was altered on this or any other day. Thus, although increased protein kinase A activity can temporarily modulate sensitized responses to cocaine, alterations in total levels of the molecules assessed in our study do not correlate with the expression of sensitized or tolerant locomotor responses to cocaine.
高剂量可卡因治疗所诱导的神经适应性变化被认为在药物治疗停止后仍会持续,并介导对可卡因的敏化和耐受表达。我们在接受更适度行为有效可卡因治疗的大鼠中寻找这些神经适应性变化的证据。大鼠接受了两种治疗方案,一种是每天注射一次、连续七天、每次剂量为15毫克/千克可卡因的敏化方案,另一种是持续输注相同每日剂量的产生耐受方案。我们评估了伏隔核和腹侧被盖区中蛋白激酶A和腺苷酸环化酶的酶活性水平,以及酪氨酸羟化酶、细胞周期蛋白依赖性激酶5和神经丝的蛋白水平。只有蛋白激酶A的活性水平因可卡因治疗而改变,但这种改变仅持续7天,而在21天时敏化的运动反应仍然明显。尽管在治疗终止后的第二天就观察到了对可卡因的行为耐受,但在这一天或其他任何一天,所评估的分子指标均未发生改变。因此,尽管蛋白激酶A活性增加可以暂时调节对可卡因的敏化反应,但我们研究中所评估分子的总体水平变化与对可卡因的敏化或耐受运动反应的表达并无关联。